Cardax Announces Interim Results from CHASE Clinical Trial

Author's Avatar
Sep 23, 2019
Article's Main Image

Pre-Specified Interim Review Demonstrated Beneficial Changes in Markers of Cardiovascular Health

- CRP, LDL, total cholesterol, triglycerides, oxidized LDL, and blood pressure reduced

- Interim results support excellent safety profile

- Enrollment continues

PR Newswire